220 related articles for article (PubMed ID: 18584918)
1. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
Batovska D; Parushev S; Stamboliyska B; Tsvetkova I; Ninova M; Najdenski H
Eur J Med Chem; 2009 May; 44(5):2211-8. PubMed ID: 18584918
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of antibacterial chalcones.
Avila HP; Smânia Ede F; Monache FD; Smânia A
Bioorg Med Chem; 2008 Nov; 16(22):9790-4. PubMed ID: 18951808
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Tomar V; Bhattacharjee G; Kamaluddin ; Kumar A
Bioorg Med Chem Lett; 2007 Oct; 17(19):5321-4. PubMed ID: 17719779
[TBL] [Abstract][Full Text] [Related]
4. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents.
Sivakumar PM; Ganesan S; Veluchamy P; Doble M
Chem Biol Drug Des; 2010 Nov; 76(5):407-11. PubMed ID: 20925692
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, physicochemical properties and antimicrobial evaluation of new (E)-chalcones.
Nowakowska Z; Kedzia B; Schroeder G
Eur J Med Chem; 2008 Apr; 43(4):707-13. PubMed ID: 17618710
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents.
Sivakumar PM; Priya S; Doble M
Chem Biol Drug Des; 2009 Apr; 73(4):403-15. PubMed ID: 19291103
[TBL] [Abstract][Full Text] [Related]
7. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action.
Nielsen SF; Larsen M; Boesen T; Schønning K; Kromann H
J Med Chem; 2005 Apr; 48(7):2667-77. PubMed ID: 15801857
[TBL] [Abstract][Full Text] [Related]
8. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
Liu XL; Xu YJ; Go ML
Eur J Med Chem; 2008 Aug; 43(8):1681-7. PubMed ID: 18031869
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
[TBL] [Abstract][Full Text] [Related]
10. Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety.
Khatib S; Nerya O; Musa R; Shmuel M; Tamir S; Vaya J
Bioorg Med Chem; 2005 Jan; 13(2):433-41. PubMed ID: 15598564
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial chalcones--bioisosteric replacement of the 4'-hydroxy group.
Nielsen SF; Boesen T; Larsen M; Schønning K; Kromann H
Bioorg Med Chem; 2004 Jun; 12(11):3047-54. PubMed ID: 15142563
[TBL] [Abstract][Full Text] [Related]
12. Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
Batovska D; Parushev S; Slavova A; Bankova V; Tsvetkova I; Ninova M; Najdenski H
Eur J Med Chem; 2007 Jan; 42(1):87-92. PubMed ID: 17007965
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor.
Abdullah MI; Mahmood A; Madni M; Masood S; Kashif M
Bioorg Chem; 2014 Jun; 54():31-7. PubMed ID: 24747187
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of substituted flavones, 4-thioflavones and 4-iminoflavones.
Ullah Mughal E; Ayaz M; Hussain Z; Hasan A; Sadiq A; Riaz M; Malik A; Hussain S; Choudhary MI
Bioorg Med Chem; 2006 Jul; 14(14):4704-11. PubMed ID: 16603364
[TBL] [Abstract][Full Text] [Related]
15. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.
Konieczny MT; Konieczny W; Sabisz M; Skladanowski A; Wakieć R; Augustynowicz-Kopeć E; Zwolska Z
Eur J Med Chem; 2007 May; 42(5):729-33. PubMed ID: 17300856
[TBL] [Abstract][Full Text] [Related]
16. Rapid identification of antibacterial agents effective against Staphylococcus aureus using small-molecule macroarrays.
Bowman MD; O'Neill JC; Stringer JR; Blackwell HE
Chem Biol; 2007 Apr; 14(4):351-7. PubMed ID: 17462570
[TBL] [Abstract][Full Text] [Related]
17. Microwave-assisted preparation of azachalcones and their N-alkyl derivatives with antimicrobial activities.
Usta A; Öztürk E; Beriş FŞ
Nat Prod Res; 2014; 28(7):483-7. PubMed ID: 24571646
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives.
Liu XH; Cui P; Song BA; Bhadury PS; Zhu HL; Wang SF
Bioorg Med Chem; 2008 Apr; 16(7):4075-82. PubMed ID: 18262793
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of chalcones with basic functionalities.
Liu X; Go ML
Bioorg Med Chem; 2007 Nov; 15(22):7021-34. PubMed ID: 17804245
[TBL] [Abstract][Full Text] [Related]
20. Antifungal and antibacterial activity of the newly synthesized 2-xanthone derivatives.
Marona H; Szkaradek N; Karczewska E; Trojanowska D; Budak A; Bober P; Przepiórka W; Cegla M; Szneler E
Arch Pharm (Weinheim); 2009 Jan; 342(1):9-18. PubMed ID: 19051197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
